fashion -WSS

fashion

author：fashion 2025-10-02 06:29:24 Page View：2

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Elizabeth Holmes on track for early release from her 11
Next article： Peter Hotez and the public health issue of online harassment

explore

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

N.Y. state detects polio case, first in the U.S. since 2013

Poliovirusescancomefromtheoralpoliovaccineusedinanumberofcountries,butnottheUnitedStates.CDC/Dr.Jose

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

Elevance PBM president out as customers face prescription chaos

MichaelConroy/APPaulMarchetti,theheadofinsurerElevanceHealth’spharmacybenefitmanager,hasleftthecompa

fashion

Wikipedia

explore

Elevance PBM president out as customers face prescription chaos